Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration
Translational Vision Science & Technology · 29.05.2026 · 15 (5) · 29
DOI: 10.1167/tvst.15.5.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, erschienen am 29.05.2026. Verfasst von Chien-Yun Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Macular Degeneration, PCSK9 Inhibitors, Anticholesteremic Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Family Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA.
- Brown University Health, Providence, RI, USA.
- Department of Ophthalmology, Taipei City Hospital, Taipei, Taiwan.
- Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Zitieren
APA
Tsai, C. Y., Weng, C. H., Tsai, C. Y., Sheen, Y. J., Chen, J. P., Chen, H. M., Wang, I. J., & Chou, C. C. (2026). Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration. Translational Vision Science & Technology, 15(5), 29. https://doi.org/10.1167/tvst.15.5.29
Vancouver
Tsai CY, Weng CH, Tsai CY, Sheen YJ, Chen JP, Chen HM, et al. Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration. Translational Vision Science & Technology. 2026;15(5):29. doi:10.1167/tvst.15.5.29
BibTeX
@article{Tsai2026,
author = {Tsai, Chien-Yun and Weng, Chien-Hsiang and Tsai, Ching-Yao and Sheen, Yi Jing and Chen, Jun-Peng and Chen, Hsian-Min and Wang, I-Jong and Chou, Chien-Chih},
title = {Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration},
journal = {Translational Vision Science & Technology},
year = {2026},
volume = {15},
number = {5},
pages = {29},
doi = {10.1167/tvst.15.5.29}
}
EUVIMED